AlphAIalphai — Financial news for AI agents
stockstotrade.comJUL 247 min read$PATH

PATH Stock Under Pressure As UBS Trims Price Target

UiPath (NYSE: PATH) shares rose about 6.27% on July 24, 2026, after UBS trimmed its price target to $12 from $13 while keeping a Neutral rating. The article cites PATH trailing revenue of about $1.61B, gross margin of 83%, and recent quarterly revenue of $418.4M. It also notes PATH last closed around $10.84 and has been in a downtrend.

Original reporting
stockstotrade.com
Published Jul 24, 2026, 8:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 10:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
PATH Stock Under Pressure As UBS Trims Price Target — source image
Source · stockstotrade.com
Decision brief

The 30-second read

$PATHBearishMed
01

Why it matters

UBS’s $13 to $12 target trim with a Neutral rating is presented as the key catalyst, aligning with a downtrend and failed attempts to reclaim the low-$12s.

02

Market read

Traders get a concrete sell-side expectation reset (UBS target cut) alongside specific chart levels ($10 support, $11.50 to $12 resistance) to guide short-term positioning.

03

What to watch

The article cites broader Street targets (mean near $13.47) and a large gap versus the recent $10.81 area, which can attract mean-reversion traders even with a Neutral rating.

Relevance 6/10Novelty 5/10Timing: today’s session, after-hours context for the July 24 move

Background

UiPath is framed as an AI automation software name with improving profitability and low leverage, but the stock has been sliding from the $12s toward $10 to $11.

Company-level read

Ticker impact

$PATHBearishMedium confidence
Context

UBS trimmed UiPath’s price target from $13 to $12 while keeping a Neutral rating, reinforcing cooling expectations amid a weak chart.

Expected impact

Near-term bias toward choppy trading, with resistance likely around the cited $11.50 to $12 zone and support near $10 to $10.85.

Evidence & confidence

The article’s only concrete new catalyst is the UBS target reduction; it does not provide new earnings, guidance, or company-specific operational updates.

Market effects

Sector

Signals cautious sentiment toward AI automation software names, potentially affecting read-across positioning for similar enterprise automation vendors.

Regional

Primarily US-listed software sentiment; no explicit cross-region catalyst described.

Global

No direct global macro or international deal/regulatory driver cited.

Counterpoint

What could challenge this read

The stock is up strongly (+6.27%) despite the UBS cut, implying dip-buying or positioning flows may outweigh target-cooling in the very short term.

Key entities

  • company
    UiPath Inc.

    Subject of the article; PATH is described as trading up on the day while still in a downtrend.

  • analyst_firm
    UBS

    Trimmed UiPath’s price target from $13 to $12 and kept a Neutral rating.

  • commentator
    StocksToTrade (Tim Bohen)

    Provides trading-style commentary emphasizing visible momentum and risk management.

Read at source← All news

Related articles

AUG 6
$PLTRHighAI 9/10

Palantir Rockets 16% After Q2 Blowout; C3.ai, UiPath Sit Out the Rally

Palantir Technologies reported Q2 2026 revenue of $1.94B, up 92.8% YoY, beating $1.81B consensus, and raised FY2026 revenue guidance to about $8.15B. U.S. commercial total contract value reached a record $2.1B. Shares rose about 16% to $145.50 after Deutsche Bank upgraded to Buy with a $200 target; C3.ai and UiPath did not rally.

yahoo.com4 min
AUG 4
$PLTRMed

JFrog, Zscaler, Palo Alto Networks, Shopify, and UiPath Shares Are Soaring, What You Need To Know

In Tuesday premarket trading, Palantir’s (PLTR) reported Q2 results and raised full-year revenue outlook drove a broad rally in enterprise software and cybersecurity peers. The article cites Palantir’s 26% jump and links the move to lower Treasury yields after geopolitical de-escalation. It also lists gains for JFrog (FROG), Zscaler (ZS), Palo Alto Networks (PANW), Shopify (SHOP), and UiPath (PATH).

financialcontent.com4 min
JUL 30
$PATHMed

UiPath (NYSE:PATH) Shares Fall as Q2 Outlook Indicates Reduced ARR Growth

NEW YORK, July 30, 2026, 2:01 p.m. EDT — Shares of UiPath NYSE:PATH declined after the company forecasted slower additions to annualized recurring revenue for the second quarter. The stock dropped 3.3% to $12.18 in early U.S. trading. Initial estimates indicate Q2 guidance suggests net new ARR between $28 million and $33 million. Initial estimate: market value, adjusted for cash, is approximately 2.8 times the projected revenue for fiscal 2027. UiPath shares declined even as U.S.

ts2.tech6 min
JUL 27
$PATHMed

PATH Stock Slips As UBS Trims Price Target

UiPath (PATH) shares were up about 7.3% on AI automation optimism, but UBS cut its price target to $12 from $13 while keeping a Neutral rating. Street consensus remains Hold with a mean target near $13.47 versus a price around $10.81. The article also cites UiPath’s annual revenue of about $1.61B and recent quarterly net income of about $22.5M.

stockstotrade.com5 min
JUL 1
$PATHMed

UiPath shares rebound as Wall Street warms to its AI-agent pivot

UiPath shares rebounded about 15% over five days after the company reported its first-quarter GAAP operating profit of $28m and GAAP profit for the first time in a first quarter, following a loss a year earlier. Revenue rose 17% to $418m; annual recurring revenue reached $1.9bn (+12%). UiPath is pivoting to AI agents, including its WorkFusion acquisition.

thenextweb.com4 min
JUN 3
$PATHMedAI 9/10

Stock Market Today, June 1: Stock Market Today, June 1: UiPath Rises After Strong Q1 Results and Raised Outlook

UiPath (NYSE:PATH) rose 11.77% to close at $13.10 after reporting fiscal Q1 2027 results and raising guidance, according to the company. The report cited 17% year-over-year revenue growth to $418 million, annual recurring revenue of $1.901 billion (+12%), and positive GAAP operating income of $28 million. Trading volume was 65.5 million shares.

finance.yahoo.com4 min